Pretreatment plasma expression of Smad7, FCGR1A, FCGR1B, and GBP1, together with TNFα genetic polymorphisms, has been shown to assist in predicting early anti-TNF responsiveness in pediatric IBD [555]. This evidence concerns the gene TNF and inflammatory bowel disease.